Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Pedley

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|July 10, 2008
Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory studyA Gaya, F Daley, N J Taylor, et al.
British Journal of Cancer|July 1, 1994
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing miceA Turner, D J King, A P Farnsworth, et al.
British Journal of Cancer|January 1, 1996
Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modificationC Delgado, R B Pedley, A Herraez, et al.
International Journal of Cancer|March 4, 2000
Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion proteinJ Bhatia, S K Sharma, K A Chester, et al.
Cancer Research|December 1, 1994
Improved tumor targeting with chemically cross-linked recombinant antibody fragmentsD J King, A Turner, A P Farnsworth, et al.
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
Immunotechnology : an International Journal of Immunological Engineering|February 1, 1996
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion proteinN P Michael, K A Chester, R G Melton, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancerK A Chester, A Mayer, J Bhatia, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Use of second antibody in radioimmunotherapyR H Begent, K D Bagshawe, R B Pedley, et al.
Disease Markers|May 22, 2001
Clinical applications of phage-derived sFvs and sFv fusion proteinsK A Chester, J Bhatia, G Boxer, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|July 10, 2008
Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory studyA Gaya, F Daley, N J Taylor, et al.
British Journal of Cancer|July 1, 1994
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing miceA Turner, D J King, A P Farnsworth, et al.
British Journal of Cancer|January 1, 1996
Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modificationC Delgado, R B Pedley, A Herraez, et al.
International Journal of Cancer|March 4, 2000
Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion proteinJ Bhatia, S K Sharma, K A Chester, et al.
Cancer Research|December 1, 1994
Improved tumor targeting with chemically cross-linked recombinant antibody fragmentsD J King, A Turner, A P Farnsworth, et al.
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
Immunotechnology : an International Journal of Immunological Engineering|February 1, 1996
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion proteinN P Michael, K A Chester, R G Melton, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancerK A Chester, A Mayer, J Bhatia, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Use of second antibody in radioimmunotherapyR H Begent, K D Bagshawe, R B Pedley, et al.
Disease Markers|May 22, 2001
Clinical applications of phage-derived sFvs and sFv fusion proteinsK A Chester, J Bhatia, G Boxer, et al.
Pageof 8